Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.32 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | PKM | P14618 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12017369 | 0.83 | TSHR (0.45) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL23509547 | 0.83 | TSHR (0.45) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL20080451 | 0.83 | TSHR (0.45) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL16715946 | 0.79 | SMN1; SMN2 (0.42) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL12017373 | 0.78 | TSHR (0.41) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL16715745 | 0.76 | TSHR (0.42) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL20080513 | 0.75 | SMN1; SMN2 (0.39) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL9509423 | 0.74 | TSHR (0.35) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL24032770 | 0.72 | TSHR (0.56) | TSHRMAPK1ALDH1A1TP53MAPT | |
| SCHEMBL9768605 | 0.72 | ALDH1A1 (0.46) | TSHRMAPK1ALDH1A1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9035018-B2 | Furan-based curable compound derived from biomass, solvent-free curable composition, and method for preparing same | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-05-19 | — | — | US | disclosed |
| US-9035018-B2 | Furan-based curable compound derived from biomass, solvent-free curable composition, and method for preparing same | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-05-19 | — | — | US | disclosed |
| US-20120220742-A1 | Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2012-08-30 | — | — | US | disclosed |
| US-20120220742-A1 | Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2012-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220742-A1 | Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same | FASN, DCXR, CBR3 | TSHR 4865/4885MAPK1 2941/4885ALDH1A1 2009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.